You are here

obesity

Novo Nordisk launches campaign for injectable weight-loss drug Wegovy

Medical Marketing and Media

Tue, 06/4/24 - 11:48 am

DTC advertising

Lilly wins NICE endorsement for tirzepatide in obesity—with a catch

Fierce Pharma

Tue, 06/4/24 - 11:38 am

type 2 diabetes

Structure Therapeutics pill leads to competitive weight loss in obesity study

BioPharma Dive

Mon, 06/3/24 - 10:26 pm

Structure Therapeutics

Weight loss drugs are so hard to find that this company built a tracker

Axios

Thu, 05/30/24 - 11:09 pm

CinCor’s ‘hub-and-spoke’ parent nabs new funding to build its next biotechs

BioPharma Dive

Thu, 05/30/24 - 11:10 am

America's doctors need more obesity medicine training

Axios

Tue, 05/28/24 - 10:49 am

Wegovy users have fewer kidney-related health problems, analysis of Novo study finds

Reuters

Sun, 05/26/24 - 12:29 pm

Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars

Reuters

Fri, 05/24/24 - 11:12 am

drug manufacturing

SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca

BioPharma Dive

Wed, 05/22/24 - 11:24 am

GLP-1 Receptor Agonist Market to Reach $125B by 2033: GlobalData

BioSpace

Mon, 05/20/24 - 06:02 pm

Genetic profile may predict best response to weight-loss drug Wegovy

Reuters

Mon, 05/20/24 - 11:09 am

Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabetes

Fierce Biotech

Thu, 05/9/24 - 11:48 am

type 2 diabetes

Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs

BioSpace

Thu, 05/9/24 - 11:43 am

Decades-old law limits access to Wegovy for Medicaid beneficiaries

NPR

Wed, 05/8/24 - 11:06 pm

Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up

BioSpace

Mon, 05/6/24 - 11:33 am

Boehringer Ingelheim

type 2 diabetes

clinical trials

Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

Motley Fool

Sun, 05/5/24 - 11:40 pm

Amgen 'encouraged' by weight-loss drug interim data, shares jump

Reuters

Thu, 05/2/24 - 10:19 pm

clinical trials

Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss

Fierce Biotech

Thu, 05/2/24 - 10:14 pm

Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans

Fierce Biotech

Wed, 05/1/24 - 11:14 pm

How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk

Yahoo Finance

Tue, 04/30/24 - 08:56 am

Pages